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Abstract
Background: Myocardial injury may contribute to unexpected deaths due to pyometra. To detect
myocardial damage, measurement of cardiac troponin I (cTnI) is currently the most sensitive and
specific method. The aims of the present study were to evaluate presence of myocardial damage in
canine pyometra by analysis of cTnI, to explore whether myocardial injury was associated with
systemic inflammatory response syndrome (SIRS) and to evaluate whether other clinical or
laboratory parameters were associated with cTnI increase.
Methods: Preoperative plasma levels of cTnI were investigated in 58 female dogs with pyometra
and 9 controls. The value of physical examination findings, haematological, serum biochemical and
pro-inflammatory (CRP and TNF-α) parameters as possible predictors of increased cTnI levels was
also evaluated.
Results: Seven dogs with pyometra (12%) and one control dog (11%) had increased levels of cTnI.
In the pyometra group, the levels ranged between 0.3–0.9 μg l-1 and in the control dog the level
was 0.3 μg l-1. The cTnI levels did not differ significantly between the two groups. No cardiac
abnormalities were evident on preoperative physical examinations. Four of the pyometra patients
died within two weeks of surgery, of which two were examined post mortem. In one of these cases
(later diagnosed with myocarditis and disseminated bacterial infection) the cTnI levels increased
from 0.9 μg l-1 preoperatively to 180 μg l-1 the following day when also heart arrhythmia was also
detected. The other patient had cTnI levels of 0.7 μg l-1 with no detectable heart pathology post
mortem. CTnI increase was not associated with presence of SIRS. There was a trend for the
association of cTnI increase with increased mortality. No preoperative physical examination
findings and few but unspecific laboratory parameters were associated with increased cTnI levels.
Conclusion:  Increased cTnI levels were observed in 12% of the dogs with pyometra. The
proportions of dogs with cTnI increase did not differ significantly in the pyometra group compared
with the control group. CTnI increase was not associated with presence of SIRS. A trend for
association of cTnI increase and mortality was observed. Preoperative physical examination findings
and included laboratory parameters were poor predictors of increased cTnI levels.
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Background
Pyometra is a common reproductive disorder which
affects nearly one fourth of all female dogs before they
reach ten years of age [1]. The disease generates clinical
signs associated with infection and inflammation in the
uterus and may induce endotoxaemia and systemic
inflammation with multiorgan effects [2,3]. Despite mod-
ern treatment routines the mortality rate due to pyometra
is about 4% [1]. Myocardial injury secondary to endotox-
aemia, inflammation, disseminated bacterial infection or
infarcation, is suspected to be a contributing factor to
unexpected deaths in female dogs with pyometra [4]. In
dogs where electrocardiography, thoracic radiography,
ultrasonography and laboratory parameters are normal,
myocardial necrosis and ischemia may be difficult to
detect clinically [5]. For definitive diagnosis heart muscle
biopsy is often required, but it is not an acceptable proce-
dure due to the risks and costs [5]. Measurement of car-
diac troponin can be useful as a non-invasive method to
determine suspected myocardial injury, for example in
cases presented with cardiac arrhythmia, severe depres-
sion or multi organ dysfunctions.
Cardiac troponin I (cTnI) analysis is a highly sensitive and
specific method for the detection of myocyte injury which
has been used to diagnose myocardial damage in many
mammalian species including humans, dogs and cats [6-
8]. Troponins are intracellular contractile-regulating pro-
teins in muscle cells and the isoenzyme cTnI is specific for
heart muscle. Since even slightly increased levels of cTnI
indicate myocyte injury, the analysis adds diagnostic and
prognostic value to other clinical examinations in identi-
fying patients at risk of cardiac events. The plasma levels
of cTnI have been shown to be associated with the severity
of myocardial injury and survival in dogs [9-11]. In
humans, cTnI analysis is the standard biomarker for myo-
cardial cell injury in heart disease [7]. In human patients
cardiac troponin measurement has also been demon-
strated to be able to predict mortality in septic, end-stage
renal disease and acute stroke, and it is suggested to be a
new mortality risk factor in intensive care units [7]. In
addition, analysis of cTnI is valuable for monitoring treat-
ment response since the concentrations directly corre-
spond to the extent of injured myocard [12,13].
Measurement of cTnI may in the future be used for these
diagnostic and prognostic purposes even in the canine
species. In dogs, increased plasma levels of cTnI have been
demonstrated in cases of toxaemia, babesiosis, myocardi-
tis, and pericardial effusion and other heart diseases
[10,11,14-16].
In canine pyometra, the role of inflammatory mediators
in myocardial disease remains to be evaluated. Analysis of
c-reactive protein (CRP) was reported to reliably predict
myocardial damage, dysfunctions and outcome in human
patients when combined with analysis of cTnI [7,12,17].
Troponin-positive human patients were demonstrated to
have increased concentrations of tumour necrosis factor-α
(TNF-α) compared with the troponin-negative ones
[7,18]. The role of TNF-α in the pathogenesis of heart dis-
eases is not completely understood [5,19].
It seems logical that dogs with pyometra and more
severely affected general condition would also be at
higher risk of developing myocardial injury. In a previous
study conducted by our laboratory group the inflamma-
tory mediator prostaglandin F2α, as measured in plasma
by its main metabolite 15-keto-13,14-dihydro-PGF2α (PG-
metabolite) was demonstrated to be increased in female
dogs with pyometra and to be associated with outcome as
measured by the length of hospitalisation [20]. In that
study, which also presented the results of history ques-
tionnaires, clinical and laboratory findings, the PG-
metabolite levels were significantly higher in pyometra
cases positive for systemic inflammatory response syn-
drome (SIRS) compared with the SIRS-negative ones.
Presence of SIRS has previously been linked with lower
survival rates and longer hospitalisation [21]. Analysis of
CRP has also shown promising predictive value for sever-
ity of pyometra [22]. The possible predictive value of cTnI
analysis in dogs with pyometra remains to be determined.
The aim of the present study was to evaluate presence of
myocardial injury by cTnI measurement in female dogs
with pyometra. Furthermore we aimed to explore whether
myocardial injury is more common in the patients with
systemic inflammatory response syndrome (SIRS) and
investigate the association of cTnI increase with other
parameters (case history, mortality, hospitalisation
length, physical examination findings, haematological
and biochemical values, TNF-α, PG-metabolite and CRP
concentrations). Detailed information on some of these
variables in pyometra, although not all the same cases, is
previously published in other studies [2,20,22].
Methods
Ethical approval
The study was approved by the Uppsala County Ethical
Board, Tierp, Sweden, prior to onset of the clinical inves-
tigations.
Animals
Pyometra group
In total 58 privately-owned bitches with the presumptive
diagnosis of pyometra were included in the present study.
The pyometra group consisted of 35 different breeds. All
bitches were treated by ovariohysterectomy at the Depart-
ment of Small Animal Clinical Sciences, Swedish Univer-
sity of Agricultural Studies, Uppsala, Sweden. The
diagnosis was based on case history, physical examinationActa Veterinaria Scandinavica 2007, 49:6 http://www.actavetscand.com/content/49/1/6
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and diagnostic imaging using ultrasonography and/or
radiography to demonstrate an enlarged, fluid-filled
uterus. The diagnosis was verified visually during the
ovariohysterectomy and confirmed by histopathological
examination at the Department of Pathology, National
Veterinary Institute, Uppsala, Sweden. The admitting cli-
nician filled out a form specifying rectal temperature,
heart rate, respiratory rate, mucus membrane colour, cap-
illary refill time, location for pain response at abdominal
palpation, hydration status and general attitude at the
time of admission. Postoperatively the heart rate, rectal
temperature and respiratory rate were noted daily on a
special form for as long as the patient was hospitalised.
The heart was monitored by auscultation each day post
surgery and if any signs of abnormalities were detected,
additional electrocardiographic examinations and blood
samplings for cTnI analysis were performed. Further infor-
mation on treatment, complication to treatment and mor-
tality were obtained from the medical records. None of
the dogs had previously been medically treated for pyom-
etra.
Control group
Healthy adult intact staff-owned female dogs (n = 9) were
included in the control group which consisted of 6 differ-
ent breeds. A history questionnaire was filled out, ensur-
ing that the owner considered the bitch healthy for at least
eight weeks prior to the examination. Complete physical
examination, including heart and lung auscultation, was
performed and documented by two of the authors who
also filled out the form specifying rectal temperature,
heart rate, respiratory rate, mucus membrane colour, cap-
illary refill time, location for any pain response at abdom-
inal palpation, hydration status and general attitude.
None of the control bitches had previously been medi-
cally treated for pyometra, nor had suffered from any uter-
ine disease at least one year after the study was finished.
Blood collection and analyses
Pyometra group
Blood samples for biochemical, haematological and PG-
metabolite analysis were obtained immediately before
surgery in EDTA, sodium-heparinised and non-additive
vacutainer tubes (Becton-Dickinson, Stockholm, Swe-
den). Biochemical and haematological analyses were per-
formed using routine methods, at the Department of
Biomedicine and Veterinary Public Health, Swedish Uni-
versity of Agricultural Sciences, Uppsala, Sweden. Ana-
lysed haematology parameters included packed cell
volume (PCV), haemoglobin (Hb), white blood cell
count (WBC), differential count of WBC including total
count (BN) and percentage band neutrophils (PBN),
nucleated erythrocytes, erythrocyte morphology, red
blood cell mean corpuscular volume (MCV), red blood
cell mean corpuscular haemoglobin concentration
(MCHC) and platelet count (PC). Analysed serum bio-
chemical parameters included alanine aminotransferase
(ALAT), albumin, alkaline phosphatase (AP), blood urea
nitrogen (BUN), cholesterol, glucose, total protein and
the electrolytes sodium (Na), potassium (K), chloride (Cl)
and calcium (Ca). For analysis of PG-metabolite, sodium
heparinised plasma was assayed at the Department of
Clinical Sciences, Swedish University of Agricultural Sci-
ences, Uppsala, Sweden. A radioimmuno assay (RIA) was
used to analyse 15-ketodihydro-PGF2α in duplicates [23].
The practical detection limit of the assay was 200 pmol l-
1. Where necessary, dilution of the samples was performed
to allow for accurate readings on the standard curve. Car-
diac troponin I was analysed using a commercially availa-
ble immunometrical method previously used in dogs for
this purpose (Immulite, Troponin I, Diagnostic Products
Corporation, Los Angeles, CA, USA) [13,14]. The detec-
tion limit for the analysis is 0.2 μg l-1, according to the
manufacturer or even lower (0.1 μg l-1) according to a
recent study [23]. Immediately after separation, the
plasma from one of the EDTA tubes was stored in two
aliquots at -70°C for TNF-α and CRP determinations.
These plasma tubes were transported to Washington State
University, Pullman, WA, USA, on dry ice and stored at -
70°C until analysis. C-reactive protein was determined by
a commercially available canine sandwich ELISA (Canine
CRP ELISA kit, TriDelta Diagnostics Inc., Plains, NJ, USA).
TNF-α concentrations were determined by a sandwich
ELISA, kindly provided by Dr. WA Buurman (University
of Maastricht, Maastricht, The Netherlands). This ELISA
test utilising this antibody experimentally in dog plasma
have shown a detection limit of 15 pg ml-1, which is 1/60
of the levels achieved after sub-lethal doses of endotoxin
[26]. This ELISA test has shown a good correlation with
the Walter and Eliza Hall Institute of Medical Research
(WEHI) bioassay and is specific for biologically active
TNF-α [26].
Control group
Blood samples from the control dogs were collected
through the same procedure as for the diseased group
after the physical examination.
Histopathological examinations
The diagnosis of pyometra, according to the previously
proposed definition was confirmed by gross and his-
topathological examination of hematoxylin-eosin stained
sections of formaldehyde-fixated uteri and ovaries at the
Department of Pathology, National Veterinary Institute
(SVA), Uppsala, Sweden [27]. Samples for histopatholog-
ical examinations were collected from several sites at both
the uterine horns and body. The definition of pyometra
was chronic purulent metritis, acute purulent metritis or
purulent endometritis.A
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Table 1: Data on selected parameters from the seven female dogs with pyometra (no. 1–7) with increased plasma levels of cardiac troponin I (cTnI).
Pyometra patient cTnI 
(μg l-1)
CRP 
(mg l-1)
PGM 
(pmol l-1)
TNF-α 
(pg ml-1)
EPC 
(1012 l-1)
PCV Hb 
(g l-1)
WBC 
(109 l-1)
PBN 
(%)
SN 
(109 l-1)
Lymph 
(109 l-1)
Crea 
(μmol l-1)
ALAT 
(μkat l-1)
AP 
(μkat l-1)
BUN 
(mmol l-1)
Alb
 (g l-1)
Chol 
(mmol l-1)
Temp 
(°C)
HR 
(beats per minute)
Age 
(years)
1* 0.9 183 33500 0.00 154 0.4 152 4.5 20.0 3.1 0.1 257 5.6 6.4 18 18 5.4 40.4 120 13.6
2 0.9 285 3100 0.13 152 0.4 154 25.6 7.8 16.9 2.0 68 0.5 14.6 6.8 35 11.1 38.7 100 10.0
3* 0.7 - 432 - 165 0.5 165 16.6 7.2 13.3 1.0 75 0.9 4.1 7.6 35 11.9 39.1 100 11.8
4 0.6 300 7300 0.15 151 0.5 151 17.9 7.3 13.4 0.2 75 0.4 12.2 12 22 9.1 38.4 134 9.6
5 0.5 - 1244 - - - - - - - - 256 0.6 9.2 23 37 14.1 39.9 164 7.1
6 0.3 369 2938 - 114 0.3 114 12.8 18.0 9.0 0.6 110 0.3 2.6 5.3 26 10.2 40.6 120 13.6
7 0.3 133 2532 0.15 119 0.3 119 16.4 18.3 11.6 1.1 50 1.1 11.6 2.9 28 6.0 39.0 160 9.5
The dogs were of the following different breeds: 1) German Shepherd, 2) Dachshund, 3) Leonberger, 4) Saluki, 5) Australian Kelpie, 6) Tibetian Spaniel, 7) Löwchen. Abbreviations used in the table: cTnI = 
cardiac troponin I; CRP = c-reactive protein; TNF-α = tumour necrosis factor α; PGM = prostaglandin F2α metabolite; EPC = red blood cell particle concentration; PCV = packed cell volume; Hb = 
haemoglobin; WBC = white blood cell count; PBN = percentage band neutrophils; SN = segmented neutrophils; Lymph = lymphocytes; Crea = creatinine; ALAT = alanine amino transferase; AP = alkaline 
phosphatase; BUN = blood urea nitrogen; Alb = albumin, Chol = cholesterol; Temp = body temperature.
* = died within two weeks of surgery.Acta Veterinaria Scandinavica 2007, 49:6 http://www.actavetscand.com/content/49/1/6
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Determination of a systemic inflammatory response
A patient was regarded as SIRS-positive if two or more of
the following criteria were met: respiratory rate > 20 min-
1; heart rate > 120 beats min-1; WBC < 6 or > 16 (× 109 l-1)
or percentage band neutrophils (PBN)> 3%; temperature
< 38.1 or > 39.2 [28]. The selected criteria have a high sen-
sitivity (97%), but a low specificity (64%) in identifying
SIRS [28]. The risk of misdiagnosing a true SIRS-positive
dog (which could have serious consequences for that dog)
is minor with the chosen criteria. Due to the low specifi-
city, however, the SIRS-positive group will include 36%
false-positive dogs.
Statistical analyses
Statistical analyses were performed with the programme
Statistica (Version 6.0, StatSoft Inc., Tulsa, USA). Spear-
man rank correlation coefficient (rs) was used to test for
associations between interval-scale variables. Values
below the detection limit, which in the data set occurred
for cTnI, PG-metabolite, BN, segmented neutrophils, eosi-
nophils, and basophils, were set to zero in the calcula-
tions. Mann-Whitney U-tests were used to test for
differences in haematological and blood chemistry
parameters between the control and pyometra group, and
Fisher's exact test was used to test for association between
detectable cTnI levels in dogs with SIRS or without SIRS,
as tested in the pyometra group. Fisher's exact test was also
used to test for association between detectable cTnI levels
and survival as tested in the pyometra group. Significance
was accepted at P < 0.05 for all statistical tests used in this
study.
Results
Cardiac troponin I in bitches with pyometra
Detectable levels of cTnI were found in 7 (12%) of the 58
pyometra female dogs. The cTnI levels ranged between
0.3–0.9 μg l-1 (Table 1). In one of the two female dogs
(no.1) with the highest preoperative cTnI levels (0.9 μg l-
1), another blood sample was obtained for cTnI analysis
the following day, which demonstrated levels of 180 μg l-
1 (Table 1). That dog died within 24 hours after the last
sample was obtained and autopsy was performed. The
death was caused by disseminated bacterial infection with
spread to various organs, including the heart where exten-
sive myocarditis was demonstrated. The other pyometra
case that was examined post mortem had preoperative
cTnI values of 0.7 μg l-1 and no pathological signs of myo-
cardial disease. Two other female dogs died within 2 days
and 2 weeks after surgery, respectively. The cTnI levels
were not increased and because no post mortem examina-
tions were performed in these cases, it is unclear whether
these deaths were consequences of the pyometra.
Cardiac troponin I in controls
The levels of cTnI were low or undetectable by means of
the chosen method, in eight of the nine control female
dogs. The remaining control dog (11%) had cTnI levels of
0.3 μg l-1.
Cardiac troponin I and survival
There was a trend for increased mortality in the pyometra
patients with detectable cTnI levels (Fisher's exact test, P =
0.067).
Cardiac troponin I and SIRS
The cTnI concentrations did not differ significantly in the
pyometra dogs with and without SIRS (Two-sample t-
tests). Detectable cTnI levels were not associated with
presence of SIRS (Fisher's exact test).
Clinical findings, biochemistry and haematological 
parameters
The pyometra and control groups differed significantly (P
< 0.05) regarding the PG-metabolite, TNF-α, and CRP lev-
els, Hb, PCV, EPC, WBC, BN, PBN, neutrophils, lym-
phocytes, monocytes, PC, AP, albumin, cholesterol,
potassium, body temperature, heart rate and age (Table
2).
Table 2: The table illustrates data on cardiac troponin I (cTnI) levels and selected parameters in the pyometra and control groups. P-
values for the significance level, median and range values are shown (Mann-Whitney U-tests).
Control Pyometra
P-value (Mann-Whitney U-test) Median (Range) n Median (Range) n
cTnIa (μg l-1) 0.949 0.00 (0.0–0.3) 9 0.00 (0.0–0.9) 58
TNF-αb (pg ml-1) 0.060 0.005 (0.0–0.01) 2 0.14 (0.0–0.41) 33
CRPc (mg l-1) 0.024 23.8 (19.6–28.0) 2 212.2 (26.4–369.0) 36
PGMd (pmol l-1) <0.001 0.0 (0–772) 9 3950 (0–33500) 58
lymphocytes (109 l-1) <0.01 2.5 (0.1–5.0) 9 1.3 (0.0–3.9) 56
BUNe (mmol l-1) 0.029 6.6 (3.5–16.3) 9 4.0 (1.6–23.1) 48
APf (μkat l-1) <0.001 1.6 (1.0–3.2) 9 4.2 (0.4–34.0) 57
ALATg (μkat l-1) 0.077 0.60 (0.3–1.3) 9 0.30 (0.1–5.6) 57
acTnI = cardiac troponin I; bTNFα = tumour necrosis factor α; cCRP = c-reactive protein; dPGM = prostaglandin F2α metabolite; eBUN = blood urea 
nitrogen; fAP = alkaline phosphatase; gALAT = alanine amino transferase.Acta Veterinaria Scandinavica 2007, 49:6 http://www.actavetscand.com/content/49/1/6
Page 6 of 8
(page number not for citation purposes)
Correlations between hospitalisation length, cardiac 
troponin I and other examined clinical and laboratory 
parameters
Hospitalisation length was not correlated with cTnI levels
but with the following parameters: duration of illness
before admission (rs = 0.295), body temperature (rs =
0.424), respiratory rate (rs = -0.315), age (rs = 0.302), TNF-
α (rs = 0.345), PG (rs = 0.453), BN (rs = 0.413), PBN (rs =
0.397), segmented neutrophils (rs = 0.337), albumin (rs =
-0.500), AP (rs = 0.451), cholesterol (rs = 0.353), mono-
cytes (rs = 0.383), MCV (rs = -0.392), WBC (rs = 0.331), Hb
(rs = -0.291), and PC (rs = -0.266).
Correlations between cardiac troponin I and other 
examined clinical and laboratory parameters
Cardiac troponin I levels were significantly (P < 0.05) cor-
related with BUN (rs = 0.320), AP (rs = 0.282), ALAT (rs =
0.266) and lymphocytes (rs = -0.246).
Discussion
In the present study, 7 of the 58 dogs with pyometra had
increased plasma levels of cTnI. The levels ranged between
0.3–0.9 μg l-1, which indicates minor myocardial damage.
Even slight elevations of cardiac troponin are specific for
myocyte injury [5]. Unnoticed myocard injury, as meas-
ured by increased cTnI levels, is frequent in critically ill
human patients and is associated with increased mortality
rates [29]. The analysis thus adds diagnostic and prognos-
tic value to other clinical examinations in identifying
patients at risk for cardiac events [29]. In humans, events
reported in the induction of myocard injury include
reduction in oxygen supply in combination with
increased myocard oxygen consumption or increasing
wall stress, hypertension with left wall hypertrophy, tach-
ycardia, infiltrative diseases, cardiac trauma, pulmonary
embolism or myocardial toxins as a consequence of sepsis
[29]. It is probable that the same types of events may
induce myocard damage also in dogs. Reference values for
plasma cTnI in healthy dogs has (in two different studies
using the same method as in the present study [13,14])
previously been determined to be < 0.5 μg l-1 and < 0.24
μg l-1. Four of the dogs with pyometra in the present study
had cTnI levels over < 0.5 μg l-1, and all had cTnI levels
above < 0.24 μg l-1.
Heart muscle injury occurs in female dogs with pyometra
for several reasons. Bacteraemia, septicaemia and dissem-
inated bacterial infection with possible subsequent myo-
carditis are not uncommon complications of the disease
[30]. Pyometra is known to induce both endotoxaemia
and SIRS, which may directly injure heart muscle cells
[3,31,32]. Multiple organ dysfunctions and coagulopa-
thies such as disseminated intravascular coagulation
(DIC) are other severe complications that can induce
myocard injury [21]. Further, the renal function is often
negatively affected in dogs with pyometra which might
lead to secondary uraemic myocardial damage [33-35]. In
the present study 53% of the pyometra dogs were SIRS-
positive, which is in the range of the proportion previ-
ously reported [2]. The hypothesis that more severely
affected animals (SIRS-positive) would also be at higher
risk of developing myocardial injury was rejected since
cTnI increase was not associated with fulfilment of criteria
for SIRS.
Cardiac troponin levels did not correlate with any of the
inflammatory markers (PG-metabolite, CRP, TNF-α)
examined in the present study. Measurement of these
parameters was thus not useful to predict or identify dogs
with increased cTnI levels despite previous reports of an
association of TNF-α with cardiac troponin and the pre-
dictive value of CRP for cardiovascular events [7,36]. Both
increased CRP and PG-metabolite levels have previously
been associated with presence of SIRS in canine pyometra
[20,22].
In the case where cardiac arrhythmia was discovered by
auscultation on the first day post surgery, the cTnI levels
were very high at that point in time (180 μg l-1), indicative
of severe myocardial injury. That dog (German Shepherd,
13.6 years old) died later during the day and the increased
level of cTnI was probably caused by the extensive myo-
carditis and disseminated bacterial infection demon-
strated on subsequent post mortem gross and
histopathological examination. The preoperative cTnI lev-
els of 0.9 μg l-1indicate that additional myocardial injury
developed after the first sample was obtained. No other
concurrent cardiac disease was identified, which could
otherwise account for the cTnI increase especially in eld-
erly female dogs with pyometra. In cases with arrhythmia
or thoracic radiograph abnormalities, it is valuable to rule
in or out cardiac muscle injury in order to optimize the
treatment. The cTnI analysis may also be functional in
managing treatment response and healing since the
plasma levels previously have been shown to be corre-
lated with the severity of myocardial injury and survival
[9-11]. Since the cTnI levels decrease to baseline within 5–
10 days of the initial injury, it is important to obtain the
blood samples as soon as myocardial injury is suspected
[8].
Only one of the control dogs in the present study had
detectable cTnI levels (0.3 μg l-1). In two previously pub-
lished studies 51% and 19 % of the tested healthy control
dogs had detectable levels of cTnI, as analysed by the same
method. Since cTnI is intracellular it should generally not
be present at all in the peripheral circulation unless some
myocardial injury has occurred [5]. However, cTnI levels
may increase minimally in healthy animals due to strenu-
ous exercise or noncardiac disease in some cases [5]. ThatActa Veterinaria Scandinavica 2007, 49:6 http://www.actavetscand.com/content/49/1/6
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the control dog in the present study had cTnI level of 0.3
μg l-1 might be due to minor damage of cardiac myocytes
which did not affect the clinical appearance, haematolog-
ical or biochemistry parameters. Since that dog was clini-
cally healthy and not further examined, the exact cause for
the cTnI increase remains unknown.
Measurement of cTnI levels in cases where an evaluation
of the heart muscle status is indicated can be valuable for
adjusting treatment and monitoring of the individual dog.
This is relevant for example in pyometra dogs with con-
current heart disease or when myocard injury can be sus-
pected. Myocyte damage, as measured by cTnI increase,
was otherwise unpredictable by preoperative findings at
physical examination and all the other laboratory param-
eters investigated in the present study. The cTnI concentra-
tions correlated with BUN, AP, ALAT and negatively with
lymphocytes. BUN, AP and ALAT generally reflect
impaired kidney or liver function and hepatocyte damage
and they are therefore poor predictors of myocyte injury.
However, troponin is cleared via the kidneys which
explain why decreased kidney function may result in
increased blood concentrations. Structural damage of
proximal tubuli and some decrease in glomerular filtra-
tion rate have been demonstrated in dogs with pyometra
[34,35]. Increased cTnI levels have also been demon-
strated in azotaemic cats and dogs [37]. Still, cTnI analysis
has been demonstrated to be useful in identifying myocar-
dial injury in human renal failure patients without overt
cardiac disease [38]. Concurrent structural cardiac disease
could also induce increased cTnI values especially in eld-
erly pyometra patients, but this was not suspected in any
of the clinical cases due to the absence of heart murmurs.
The cTnI levels were also not associated with increasing
age. The clinical significance of minor cTnI increase still
remains to be determined in dogs without clinical signs of
cardiac dysfunction.
Potential life-threatening consequences of pyometra
include endotoxaemia, bacteraemia, septicaemia, SIRS,
DIC, multiple organ dysfunctions and disseminated bac-
terial infection of vital organs [2,21,29]. To evaluate the
predictive value of cTnI for survival, an increased patient
number is necessary since only two female dogs died of
causes related to pyometra. In the second confirmed fatal-
ity, a dog with a thin-walled uterus which ruptured during
surgery, the dog died within one hour after surgery was
completed. This bitch had preoperative cTnI values of 0.7
μg l-1 and no pathological signs of heart muscle disease on
the autopsy (histopathological and gross examination).
Of the remaining two fatalities one occurred two weeks
after surgery, and the other one day after surgery, shortly
after departure from the veterinary clinic. Whether these
deaths were associated with complications of the pyome-
tra or related to heart dysfunction is unclear since no
autopsies were performed. In both these female dogs cTnI
was not detected in the plasma preoperatively. The four
pyometra patients that died ranged between 8.1–13.6
years of age. Two of the seven pyometra dogs with detect-
able cTnI levels died (28%) in comparison with two of the
fifty-one pyometra dogs without cTnI increase (4%). A
trend for the association of detectable cTnI levels with
increased mortality was apparent when evaluated in the
pyometra group (P = 0.067).
As for prognostic value, the cTnI levels were not correlated
with the outcome as measured in this study by length of
the hospitalisation. Pyometra cases overiohysterect-
omised at our clinic are generally dismissed 1–2 days after
surgery. Additional complications lead to longer hospital-
isation. Although a relatively crude measurement, length
of hospitalisation has previously been used for this pur-
pose in studies of human diseases [39] and in dogs [2,20].
Conclusion
Minor myocardial injury was present in 12% of the female
dogs with pyometra. The proportions of cases with
increased cTnI levels did not differ significantly in the
pyometra patient group when compared with healthy
control dogs. Presence of SIRS was not associated with
increased cTnI values. A trend for the association of detect-
able cTnI levels with increased mortality was apparent, as
evaluated in the pyometra group. Findings at physical
examination, haematological, biochemical and inflam-
matory parameters evaluated preoperatively in the present
study, were all poor predictors of myocardial cell injury as
determined by cTnI analysis.
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